FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

Fisher & Paykel Healthcare Corporation Limited

Equities

FPH

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

End-of-day quote New Zealand S.E. Other stock markets 06:00:00 2024-07-07 pm EDT			5-day change	1st Jan Change
29.83 ^NZD	-0.20%		-0.40%	+26.40%

May. 29	Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2025	CI
May. 29	Fisher & Paykel Healthcare Corporation Limited Announces Final Dividend for the Full Year 2024, Payable on 10 July 2024	CI

Fisher & Paykel Healthcare Corporation Limited Announces Revenue Results for the Nine Months Ended 31 December 2020

January 21, 2021 at 03:27 pm EST

Fisher & Paykel Healthcare Corporation Limited announced revenue results for the nine months ended 31 December 2020. Operating revenue for the nine months ended 31 December 2020 was up 73% in constant currency compared to the prior comparable period.

Latest news about Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2025	May. 29	CI
Fisher & Paykel Healthcare Corporation Limited Announces Final Dividend for the Full Year 2024, Payable on 10 July 2024	May. 29	CI
Fisher & Paykel Healthcare Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 29	CI
New Zealand Shares Flat; Fisher & Paykel Healthcare's Fiscal 2024 Net Profit Falls	May. 29	MT
Fisher & Paykel Healthcare's Net Profit Nearly Halves in Fiscal Year 2024; Shares Rise 6%	May. 28	MT
Transcript : Fisher & Paykel Healthcare Corporation Limited, 2024 Earnings Call, May 29, 2024	May. 28
New Zealand Shares Fall for Second Day; Fisher & Paykel Healthcare Launches Apnea Mask	Apr. 09	MT
Fisher & Paykel Begins Selling Lightest Mask for Sleep Apnea	Apr. 08	MT
JPMorgan Upgrades Fisher & Paykel Healthcare to Neutral from Underweight; Price Target is NZ$24.00	Mar. 28	MT
New Zealand Shares Jump on Rate Cut Hopes; WasteCo Raises NZ$3 Million from Convertible Bond Offer	Mar. 28	MT
Fisher & Paykel Issues Limited Recall of Airvo Devices; Flags NZ$12 Million Hit	Mar. 27	MT
Fisher & Paykel Healthcare Corporation Limited Initiates Voluntary Limited Recall of Airvo 2 and myAirvo 2 Devices Manufactured Before 14 August 2017	Mar. 27	CI
Fisher & Paykel Healthcare Expects NZ$1.73 FY Billion Operating Revenue	Mar. 21	MT
Fisher & Paykel Healthcare Corporation Limited Revises Earnings Guidance for the Financial Year Ending 31 March 2024	Mar. 21	CI
New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire	Mar. 07	MT
Fisher & Paykel Healthcare's Chair to Retire	Mar. 07	MT
Fisher & Paykel Healthcare Corporation Limited Announces Board Changes	Mar. 07	CI
Morgan Stanley Adjusts Fisher & Paykel Healthcare’s Price Target to NZ$24.12 From NZ$23.12, Keeps at Equalweight	Mar. 05	MT
Morgan Stanley Adjusts Fisher & Paykel Healthcare’s Price Target to AU$22.19 From AU$21.50, Keeps at Equalweight	Mar. 05	MT
Australian shares gain as financials shine; market focus on inflation data	Feb. 23	RE
New Zealand shares snap 4-day rally but set for weekly gain; Australia closed	Jan. 25	RE
New Zealand Shares Rise on Strong Trading in Services Sector	Dec. 26	MT
Fisher & Paykel Healthcare Appoints COO	Dec. 20	MT
Fisher & Paykel Healthcare Corporation Limited Announces Board Changes	Dec. 19	CI
ResMed, Inc. continues to make headway in the sleep market	Dec. 11

Chart Fisher & Paykel Healthcare Corporation Limited

Duration

Period

Chart Fisher & Paykel Healthcare Corporation Limited

More charts

Company Profile

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Companyâs products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-27 - Annual General Meeting

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Ratings for Fisher & Paykel Healthcare Corporation Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

29.83 NZD

Average target price

25.95 NZD

Spread / Average Target

-13.01%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	+26.40%	10.71B
ABBOTT LABORATORIES	-7.22%	181B
MEDTRONIC PLC	-6.72%	99.52B
BECTON, DICKINSON AND COMPANY	-7.50%	65.82B
DEXCOM, INC.	-10.57%	45.21B
CENCORA, INC.	+8.92%	43.85B
HOYA CORPORATION	+11.01%	42.17B
METTLER-TOLEDO INTERNATIONAL, INC.	+9.65%	28.75B
TERUMO CORPORATION	+18.54%	25.39B
WEST PHARMACEUTICAL SERVICES, INC.	-9.13%	23.5B

Other Medical Equipment, Supplies & Distribution